Antidepressant efficacy of ketamine plus naltrexone for major depression comorbid with alcohol use disorder: a randomized controlled trial

Authors

Institutions

Publication Details

Journal
The International Journal of Neuropsychopharmacology
Published
2025-08-01
DOI
https://doi.org/10.1093/ijnp/pyaf056
Citations
3
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
4.18
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antidepressant efficacy of ketamine plus naltrexone for major depression comorbid with alcohol use disorder: a randomized controlled trial

Ismene L. Petrakis, Brian Pittman, Elizabeth Ralevski, John Harrison Krystal et al.
3 citations
The International Journal of Neuropsychopharmacology
Treatment of Major Depression
4.18
article

Antidepressant efficacy of ketamine plus naltrexone for major depression comorbid with alcohol use disorder: a randomized controlled trial

Ismene L. Petrakis, Brian Pittman, Elizabeth Ralevski, John Harrison Krystal, Gihyun Yoon
article en
3 citations

Abstract

No abstract available for this paper.
The International Journal of NeuropsychopharmacologyVol. 28(8)
Yale University (US), VA Connecticut Healthcare System (US)
Openalex Percentile: Top 6%
Treatment of Major Depression
4.18
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.